Balance of Power measures where the close finished relative to the open, showing whether buyers or sellers controlled the session.
Daily Balance Of Power Analysis Today
Balance of Power measures where the close finished relative to the open, showing whether buyers or sellers controlled the session. The current Daily Balance Of Power for Fate Therapeutics is -0.27. This reading indicates elevated price movement across the session.
On May 10 2026 Fate Therapeutics was traded for 2.39 at the closing time. The top price for the day was 2.47 and the lowest listed price was 2.32 . Trading activity remained within a narrow range during the period. Price movement on May 10, 2026 remained within defined bounds. The net trading delta against the current closing price is 0.42% .
BOP trending toward the high of its range signals sustained buying pressure on Fate Therapeutics. A decline from positive toward zero suggests weakening demand. Conversely, BOP moving from deeply negative toward zero indicates diminishing selling pressure. Divergence between BOP direction and price direction may signal a pending reversal.
Related Price-Series Methods for Fate Therapeutics
These methods summarize the same price history through smoothing, range, and momentum calculations. Reviewing them alongside Daily Balance Of Power helps compare stable sessions with periods of wider price movement in Fate Therapeutics.
Sizing up Fate Therapeutics against these stocks within the Health Care space shows how it compares on key financial measures. Growth rate gaps between Fate Therapeutics and its peers often explain pricing differences in the market.
Accumulation/Distribution and Balance of Power for Fate Therapeutics reveal whether buying or selling pressure dominates recent sessions. Balance of Power trending positive indicates that buyers are consistently closing Fate Therapeutics near session highs. These signals help explain whether price direction and session structure are moving together for Fate Therapeutics.
Risk indicator analysis for Fate Therapeutics quantifies how much price variability the stock has exhibited over the measurement window. Downside variance exceeding total variance indicates that negative moves in Fate Therapeutics have been larger or more frequent than positive ones. Mean deviation provides a more intuitive measure of typical price fluctuation than variance because it stays in the same units as Fate Therapeutics' price.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Fate Therapeutics Short Properties
Short sentiment tied to Fate Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. A disciplined short-interest review can make timing decisions more informed under rising skepticism.